0000897069-24-001927.txt : 20241007 0000897069-24-001927.hdr.sgml : 20241007 20241007154754 ACCESSION NUMBER: 0000897069-24-001927 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241007 DATE AS OF CHANGE: 20241007 EFFECTIVENESS DATE: 20241007 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Morphoceuticals, Inc. CENTRAL INDEX KEY: 0001962989 ORGANIZATION NAME: IRS NUMBER: 844555716 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-526068 FILM NUMBER: 241357733 BUSINESS ADDRESS: STREET 1: 200 BOSTON AVENUE STREET 2: SUITE G-725 CITY: MEDFORD STATE: MA ZIP: 02155 BUSINESS PHONE: 858-603-2514 MAIL ADDRESS: STREET 1: 200 BOSTON AVENUE STREET 2: SUITE G-725 CITY: MEDFORD STATE: MA ZIP: 02155 D 1 primary_doc.xml X0708 D LIVE 0001962989 Morphoceuticals, Inc. 200 Boston Avenue Suite G-725 Medford MA MASSACHUSETTS 02155 858-603-2514 DELAWARE None None Corporation true 2020 James Jenson 200 Boston Avenue Suite G-725 Medford MA MASSACHUSETTS 02155 Executive Officer Director Michael R. Hufford 200 Boston Avenue Suite G-725 Medford MA MASSACHUSETTS 02155 Director Alexander Pickett 200 Boston Avenue Suite G-725 Medford MA MASSACHUSETTS 02155 Director Rosemarie Hunziker 200 Boston Avenue Suite G-725 Medford MA MASSACHUSETTS 02155 Director Justin Briggs 200 Boston Avenue Suite G-725 Medford MA MASSACHUSETTS 02155 Director Tamim Hamad J.J Al-Thani 200 Boston Avenue Suite G-725 Medford MA MASSACHUSETTS 02155 Director Biotechnology Decline to Disclose 06b false 2024-09-23 false true false 0 5500000 3500000 2000000 false 1 0 0 0 false Morphoceuticals, Inc. James Jenson James Jenson Chief Executive Officer 2024-10-07